The mechanism of hypoglycemia for NICTH is through excess production of insulin-like growth factor 2 (IGF-2) and IGF-2 precursors secreted by underlying tumors and its insulin-like downstream effects mediated via insulin receptor activation. The gene discussed is INS; the disease is Hypoglycemia.